Modern drug discovery pushes the boundaries of what is possible in a wider range of illnesses than ever before. This is a highly competitive landscape where the key factors for success are time, efficiency and high quality science. Integrated drug discovery answers these needs by executing an iterative, interdisciplinary approach which is robust, agile and efficient. With the right scientific team, the discovery and development of high-quality drug candidates is far more likely to be successful
At IRBM, we accelerate your drug discovery projects, from target validation to candidate nomination, through a passion for science, unique tools and state-of-the-art facilities. Seamless transitions, thanks to the collaborative approach of our scientific team, provide strong industrial expertise, flexibility and a faster time to the clinic.
With 4 drugs on the market and over 25 candidates delivered, our scientific team understands that each integrated discovery project is unique. We adapt to each challenge by delivering customized, multidisciplinary solutions, defining project goals and candidate requirements together with our clients. We execute the project by leveraging our team’s problem-solving capabilities and scientific know-how, to deliver superior drug candidates in a compressed time frame and in a cost-effective manner.
We can execute a wide variety of drug discovery programs capitalizing on our expertise in multiple modalities, including small molecules, peptides, and antibodies. When working with us, you can benefit from:
- Broad experience in developing different types of therapeutic agents
- Optimized, integrated expertise spanning from target validation to candidate selection, with both in vitro and in vivo capabilities
- Reduced timelines and faster program progression
- A single point of contact for your drug discovery program, reducing complexity and the resources needed to manage the project
- Innovative scientific advice and insights from a team of passionate experts
- A flexible approach to drug discovery for a higher-quality drug candidate with well-optimized properties, to increase the POS of your projects
- Strong support for IP analyses and protection
- Unique, proprietary libraries (small molecules and phage display of peptides and mAbs)
Whatever your needs, our team can support your research, accelerate your integrated drug discovery programs and deliver high-quality candidates to enter the clinic, leaving you free to focus on what comes next.